Thermo Fisher Scientific Inc.
TMO · NYSE
9/27/2025 | 6/28/2025 | 3/29/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $175 | $154 | $189 | $199 |
| - Cash | $2 | $5 | $4 | $4 |
| + Debt | $36 | $35 | $34 | $33 |
| Enterprise Value | $209 | $185 | $219 | $228 |
| Revenue | $11 | $11 | $10 | $11 |
| % Growth | 2.5% | 4.7% | -9% | – |
| Gross Profit | $5 | $4 | $4 | $4 |
| % Margin | 41.8% | 37.3% | 41% | 39.2% |
| EBITDA | $3 | $3 | $3 | $3 |
| % Margin | 25.5% | 25.8% | 25.4% | 26.9% |
| Net Income | $2 | $2 | $2 | $2 |
| % Margin | 14.5% | 14.9% | 14.5% | 16.1% |
| EPS Diluted | 4.27 | 4.28 | 3.98 | 4.78 |
| % Growth | -0.2% | 7.5% | -16.7% | – |
| Operating Cash Flow | $2 | $1 | $1 | $3 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $2 | $1 | $0 | $3 |